A Unified Approach to Targeting the Lysosome's Degradative and Growth Signaling Roles [Research Articles]

This study identifies chemical features of dimeric compounds that increase their lysosomal specificity, and a new molecular target for these compounds, reclassifying these compounds as targeted therapies. Targeting PPT1 blocks mTOR signaling in a manner distinct from catalytic inhibitors, while concurrently inhibiting autophagy, thereby providing a new strategy for cancer therapy. Cancer Discov; 7(11); 1266–83. ©2017 AACR.
See related commentary by Towers and Thorburn, p. 1218.
This article is highlighted in the In This Issue feature, p. 1201

Source: Cancer Discovery - November 1, 2017 Category: Cancer & Oncology Authors: Rebecca, V. W., Nicastri, M. C., McLaughlin, N., Fennelly, C., McAfee, Q., Ronghe, A., Nofal, M., Lim, C.-Y., Witze, E., Chude, C. I., Zhang, G., Alicea, G. M., Piao, S., Murugan, S., Ojha, R., Levi, S. M., Wei, Z., Barber-Rotenberg, J. S., Murphy, M. E., Tags: Research Articles Source Type: research